© 2019 DAMP Lab. The facility is funded by NSF grant #1253856.

  • Grey YouTube Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

New Publication: “Standardizing Automated DNA Assembly: Best Practices, Metrics, and Protocols Using Robots

Boston - February 2019
Boston - February 2019

DAMP Lab Mentioned in the Publication "Improving Reproducibility in Synthetic Biology"

Denmark - February 2019
DztBNvmWoAA6M_5.jpg

DAMP Lab in the process to be a member of the IGSC consortium  

Boston - September 2018

Take a look in our partnership with Opentrons (specially after minute 38). We have both OT1 and OT2 robots in our lab and they are changing the way we deal with synthetic biology automation... for better!

The International Gene Synthesis Consortium (IGSC) is an industry-led group of gene synthesis companies and organizations formed to design and apply a common protocol to screen both the sequences of synthetic gene orders and the customers who place them. In addition, the consortium works with national and international government organizations and other interested parties to promote the beneficial application of gene synthesis technology while safeguarding biosecurity.

Members of the IGSC include: Ginkgo, IDT DNA, SGI-DNA, EGF, among others. We, from the DAMP Lab, are looking for contributing to make the use of synthetic DNA safe and responsible, as a member of IGSC.

 

 

Collaboration DAMP Lab and Opentrons Pictured at SynbioBeta Live!

Take a look in our partnership with Opentrons (specially after minute 38). We have both OT1 and OT2 robots in our lab and they are changing the way we deal with synthetic biology automation... for better!

San Francisco - August 2018
Global Biofoundry Alliance
London - June 2018

A meeting was held at Imperial College London on June 21st/22nd 2018, which gathered fifteen (see below) of the leading synthetic biology biofoundries from around the world to discuss current activities and exchange information on key capabilities and projects being developed by these groups. The meeting explored opportunities for collaboration and coordination in areas for global development including standards, software, metrology, automation, and industrial translation. Delegates unanimously indicated a commitment to sharing pre-competitive knowledge and expertise that would collectively benefit the synthetic biology and broader biotechnology communities worldwide. Interest in developing common protocols and standards, as well as standardised legal tools, to reduce the transaction costs of sharing were among the highlights of the two-day interactive meeting. Other areas of discussion included collective engagement with industry, governments, and other relevant organizations to achieve joint objectives, break down barriers to sharing and leverage interactive opportunities for growth. There was a general commitment to continue to explore the possibility of establishing a global alliance of synthetic biology biofoundries and work together to define and agree on an operating model. As a starting point, an annual meeting was proposed as was the establishment of small working groups to develop specific areas for global development.

DAMP, Boston University (US); DOE Agile Biofoundry (US); SIAT Shenzhen (China) Foundry; Concordia University (Canada); Earlham Institute (UK); London DNA Foundry Imperial College (UK); Kobe University (Japan); Macquarie University (Australia); SynCTI NUS (Singapore); Novo Nordisk Foundation Center for Biosustainability DTU (Denmark); Tianjin University (China)l Edinburgh Genome Foundry (UK); BioFAB University of Illinois (US); GeneMill, University of Liverpool; SYNBIOCHEM University of Manchester (UK).